Site Search
Search Results
Governor Signs Legislation that Provides Access to Precision Treatment for All Oklahomans
... Bill 513 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. “ACS CAN thanks Sen. Paul Rosino for his leadership on biomarker testing legislation and Gov. Stitt for signing this important piece of legislation,” said Matt Glanville, Oklahoma government relations director for the American Cancer Society Cancer Action Network (ACS CAN) . “This legislation will help dismantle barriers and bring the promise of precision medicine to cancer patients no matter their income, race, or where they live. This will provide many benefits to patients, including ...
Proposed Law to Expand Access to Biomarker Testing in Colorado Passes Committee
Link to video DENVER, COLO. – FEBRUARY 23, 2023 – The American Cancer Society Cancer Action Network (ACS CAN) applauds members of the Health & Insurance committee for passing House Bill 1110, Health-care Coverage for Biomarker Testing , this week. The ... (D) and Rep. Anthony Hartsook (R), aims to expand access to biomarker testing in Colorado. Biomarker testing has become a game-changing part of cancer care in recent years as it’s a necessary first step in opening the door to targeted treatments that can lead to survivorship and ...
Pennsylvania Cancer Action Day 2024
... together from across the state to advocate for life-saving policies. No prior experience is needed, we will provide training and resources ahead of time and book lawmaker meetings for you. All you need to bring is your passion in the fight against cancer. See you at the Capitol! Here is ... policies/the asks we will be making, guidance for your lawmaker meetings, and logistical information: Training Manual PDF The training deck can be found here: Training Deck PDF If you are in a House or Senate meeting with 3+ constituents, you will have a Meeting Captain to help ... wipe out $400 million in medical debt (budget ask) In a 2022 ACS CAN survey, 73% of cancer survivors said they are worried about affording the cost of their current or future cancer care. Medical debt may have a direct effect on cancer care: high costs can lead to delayed treatment. ...
2024 West Virginia Cancer Action Day Webpage
... shop for all the necessary resources to prepare for your participation in successful lawmaker conversations on February 12th. We know that part of the magic that goes into an impactful Cancer Action Day is preparation, coordination, and resources - coupled with our pre-event ... Recording 24_wv_volunteer_training_presentation_.pdf Biomarker Fact Sheets Mentioned in the Pre-Training: biomarker_testing_costs_and_cost_savings.pdf acs_can_biomarker_testing_patient_profiles_final_0.pdf health_equity_in_biomarker_testing_and_targeted_therapy_.pdf biomarker_testing_faq_.pdf ...
2023 Kentucky Cancer Action Day Webpage
... locate all the necessary resources to prepare for your participation in successful lawmaker conversations on February 16th. We know that part of the magic that goes into an impactful Cancer Action Day is preparation, coordination, and resources - coupled with our pre-event ... Training Recording 23_ky_volunteer_training_presentation_final.pdf Fact sheets Mentioned in the Pre-Training: biomarker_testing_costs_and_cost_savings.pdf acs_can_biomarker_testing_patient_profiles_final_0.pdf health_equity_in_biomarker_testing_and_targeted_therapy_.pdf biomarker_testing_faq_.pdf ...
House Passes Legislation That Won’t Improve Health Outcomes
... The following is a statement from Doug Hogan, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) urges the Senate to amend House Bill 4753, the biomarker ... tests that can allow them to benefit from the right treatments at the right time – often leading to improved health outcomes, better quality of life, and ultimately cost savings – but this legislation falls short of those goals. “Biomarker testing and precision medicine are helping extend and improve ...
Survivor Views: One in Ten Impacted by Recent Drug Shortages
Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... they were a good candidate for it, however most (69%) did not discuss it with their doctor. Nine percent did not have biomarker testing due to cost or coverage concerns. Telehealth Four-in-five agree it is important for cancer patients to have access to telehealth services from out of ...
Cancer Patients and Survivors Urge Legislators to Make Biomarker Access a Priority, Eliminate Flavored Tobacco Sales
... Washington gathered at the Capitol building Monday to ask legislators to support House Bill 1062, which would expand insurance coverage of biomarker testing, making sure as many state residents as possible have access to this technology. Biomarker testing is about identifying the most effective treatment for patients with cancer and other serious illnesses. It can open the door to precision treatments that can improve outcomes and quality of life for patients with many diseases and conditions. Similar legislation has passed in 20 states including California, Texas, Georgia and ...
More Californians with Cancer, Other Chronic Diseases, Get Access to Game-Changing Testing
Sacramento , Calif. – Gov. Gavin Newsom signed the state budget on June 29, allowing for Medi-Cal implementation of Senate Bill 496. Starting July 1st, Medi-Cal and other state-regulated health insurance plans will cover comprehensive biomarker testing ... Testing for specific biomarkers – such as gene mutations – found in blood, tissues or other biospecimens provides crucial information that can help determine the most effective treatment for a particular patient, including precision medicine and targeted therapies. “Nearly 60% of all cancer drugs approved in the last five years require or recommend biomarker testing before use. Improving coverage for biomarker testing ...
Rhode Island Senate Votes to Remove Barriers to Biomarker Testing
... right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes – biomarker testing being one of the ways we can achieve these outcomes by allowing doctors to understand and target unique markers in a patient’s cancer cells. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due in part to lack of coverage by private health insurance and Medicaid for needed testing. Senate Bill 2201 aims to enable more ...
Type
Priority Issue
State
- New York (12) Apply New York filter
- Pennsylvania (9) Apply Pennsylvania filter
- California (7) Apply California filter
- New Jersey (7) Apply New Jersey filter
- Ohio (7) Apply Ohio filter
- Florida (5) Apply Florida filter
- Maine (4) Apply Maine filter
- West Virginia (4) Apply West Virginia filter
- Georgia (3) Apply Georgia filter
- Hawaii (3) Apply Hawaii filter
- Maryland (3) Apply Maryland filter
- Massachusetts (3) Apply Massachusetts filter
- Washington (3) Apply Washington filter
- Connecticut (2) Apply Connecticut filter
- Indiana (2) Apply Indiana filter
- New Hampshire (2) Apply New Hampshire filter
- New Mexico (2) Apply New Mexico filter
- North Carolina (2) Apply North Carolina filter
- Oklahoma (2) Apply Oklahoma filter
- Colorado (1) Apply Colorado filter
- Delaware (1) Apply Delaware filter
- Iowa (1) Apply Iowa filter
- Kentucky (1) Apply Kentucky filter
- Louisiana (1) Apply Louisiana filter
- Michigan (1) Apply Michigan filter
- Minnesota (1) Apply Minnesota filter
- Nevada (1) Apply Nevada filter
- Rhode Island (1) Apply Rhode Island filter
- Tennessee (1) Apply Tennessee filter
- Texas (1) Apply Texas filter
- Vermont (1) Apply Vermont filter